These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Evolving paradigm in the management of allergic rhinitis-associated ocular symptoms: role of intranasal corticosteroids. Blaiss MS. Curr Med Res Opin; 2008 Mar; 24(3):821-36. PubMed ID: 18257976 [Abstract] [Full Text] [Related]
24. A comparison of intranasal corticosteroid, leukotriene receptor antagonist, and topical antihistamine in reducing symptoms of perennial allergic rhinitis as assessed through the Rhinitis Severity Score. Sardana N, Santos C, Lehman E, Craig T. Allergy Asthma Proc; 2010 Mar; 31(1):5-9. PubMed ID: 20167140 [Abstract] [Full Text] [Related]
28. Is there a role for leukotriene antagonists in the prevention of recurrent nasal polyps? Rasp G. Curr Opin Allergy Clin Immunol; 2010 Jun; 10(3):200-5. PubMed ID: 20431368 [Abstract] [Full Text] [Related]
29. Montelukast in allergic rhinitis: a systematic review and meta-analysis. Grainger J, Drake-Lee A. Clin Otolaryngol; 2006 Oct; 31(5):360-7. PubMed ID: 17014443 [Abstract] [Full Text] [Related]
32. Role of leukotriene antagonists and antihistamines in the treatment of allergic rhinitis. Cobanoğlu B, Toskala E, Ural A, Cingi C. Curr Allergy Asthma Rep; 2013 Apr; 13(2):203-8. PubMed ID: 23389557 [Abstract] [Full Text] [Related]
33. The emerging role of leukotriene modifiers in allergic rhinitis. Grayson MH, Korenblat PE. Am J Respir Med; 2003 Apr; 2(6):441-50. PubMed ID: 14719983 [Abstract] [Full Text] [Related]